The first Big Red STEM Day exposed high school students from communities underrepresented in science, technology, engineering and mathematics to educational and career opportunities in those fields.
High blood pressure transforms cells of the immune system that reside around cerebral blood vessels and normally protect the brain into agents of cognitive decline, according to new research from Weill Cornell Medicine scientists.
Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine announced Oct. 31 that they have established a new drug discovery company called Bridge Medicines.
To advance a powerful cancer treatment strategy that uses immune cells to fight the disease, Ellen and Gary Davis '76 have made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy.
Cornell researchers received a $500,000 grant from the Centers for Disease Control and Prevention to help in a national initiative to combat drug-resistant organisms, sometimes referred to as "superbugs."
New research by Weill Cornell Medicine shows chemotherapy kills the most common type of bladder cancer, urothelial cancer, but it also shapes genetic evolution of remaining urothelial cancer cells.
Two Weill Cornell Medicine faculty members, Dr. Francis Lee and Dr. Jane Salmon, were elected to National Academy of Medicine, it was announced Oct. 17.
An overactive gene appears to cause some prostate cancers to transform from a typical tumor type to a much more aggressive form of the disease, according to new research at Weill Cornell Medicine.
